Directorio de personas
Sonia Gatius Caldero

Sonia Gatius Caldero

Grado: Doctor/a

973 705312
sgatius.lleida.ics(ELIMINAR)@gencat.cat

Grupos

Publicaciones

  • Matas-Nadal, C; Gatius, S; Ribes-Santolaria, M; Guasch-Vallés, M; Arbones, XG; Casanova, JM; Aguayo-Ortiz, RS; Gari, E

    FABP5 in keratinocyte carcinomas: expression, secretion, and its impact on tumor aggressiveness

    ARCHIVES OF DERMATOLOGICAL RESEARCH 316 342-342. .

    [doi:10.1007/s00403-024-03111-z]

  • Bermúdez JRT; Salinas CAS; Calderó SG; Rombolá CA

    Lung cancer associated to cystic airspaces: surveillance for early diagnosis.

    CIRUGIA ESPANOLA 102 350-350. .

    [doi:10.1016/j.cireng.2023.10.012]

  • Pueyo Balsells N; Barriuso I; Gambó Ruberte E; Gatius S; Santamaría Gómez M

    Cathecolaminergic storm with stress-induced cardiomyopathy secondary to pheochromocytoma.

    MEDICINA CLINICA 162 -. .

    [doi:10.1016/j.medcli.2023.09.027]

  • Albertí-Valls M; Megino-Luque C; Macià A; Gatius S; Matias-Guiu X; Eritja N

    Metabolomic-Based Approaches for Endometrial Cancer Diagnosis and Prognosis: A Review.

    Cancers 16 -. .

    [doi:10.3390/cancers16010185]

  • Gatius S; Matias Guiu X; Davidson B

    Molecular features for timely cancer diagnosis and treatment - tumors of the ovary, fallopian tube and endometrium.

    VIRCHOWS ARCHIV 484 339-351. .

    [doi:10.1007/s00428-023-03710-7]

  • Dorca, E; Velasco, A; Varela, M; Gatius, S; Villatoro, S; Fullana, N; Cuevas, D; Vaquero, M; Birnbaum, A; Neumann, K; Matias-Guiu, X

    Validation of Modaplex POLE mutation assay in endometrial carcinoma

    VIRCHOWS ARCHIV 483 787-794. .

    [doi:10.1007/s00428-023-03636-0]

  • Polanco, D; Pinilla, L; Gracia-Lavedan, E; Gatius, S; Zuil, M; Pardina, M; Gomez, S; Barbe, F

    Performance of endobronchial ultrasound transbronchial needle aspiration as the first nodal staging procedure for the determination of programmed death ligand-1 expression in non-small cell lung cancer patients

    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 149 12459-12468. .

    [doi:10.1007/s00432-023-05039-9]

  • Navaridas, R; Vidal-Sabanés, M; Ruiz-Mitjana, A; Altés, G; Perramon-Güell, A; Yeramian, A; Egea, J; Encinas, M; Gatius, S; Matias-Guiu, X; Dolcet, X

    In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers

    Advanced Science 10 -. .

    [doi:10.1002/advs.202303134]

  • Matas-Nadal C; Bech-Serra JJ; Gatius S; Gomez X; Ribes-Santolaria M; Guasch-Vallés M; Pedraza N; Casanova JM; Gómez CT; Garí E; Aguayo-Ortiz RS

    Biomarkers found in the tumor interstitial fluid may help explain the differential behavior among keratinocyte carcinomas.

    MOLECULAR & CELLULAR PROTEOMICS 22 100547-100547. .

    [doi:10.1016/j.mcpro.2023.100547]

  • Lopez-Mejia IC; Pijuan J; Navaridas R; Santacana M; Gatius S; Velasco A; Castellà G; Panosa A; Cabiscol E; Pinyol M; Coll L; Bonifaci N; Peña LP; Vidal A; Villanueva A; Gari E; Llobet-Navàs D; Fajas L; Matias-Guiu X; Yeramian A

    Oxidative stress-induced FAK activation contributes to uterine serous carcinoma aggressiveness.

    MOLECULAR ONCOLOGY 17 98-118. .

    [doi:10.1002/1878-0261.13346]

  • Matas-Nadal C; Soria X; Gonzalez-Farré M; Baradad M; Tuset N; Rius Riu F; González M; Gatius S; Vilardell F; López-Ortega R; María Martí R

    Abdominal tumors in patients with neurofibromatosis type I: Genotype-phenotype relationships.

    European Journal of Medical Genetics 65 104609-104609. .

    [doi:10.1016/j.ejmg.2022.104609]

  • Egan D; Moran B; Wilkinson M; Pinyol M; Guerra E; Gatius S; Matias-Guiu X; Kolch W; le Roux CW; Brennan DJ

    CRABP2 - A novel biomarker for high-risk endometrial cancer.

    GYNECOLOGIC ONCOLOGY 167 314-322. .

    [doi:10.1016/j.ygyno.2022.09.020]

Proyectos

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • Clinical and functional identification of metastatic colonization biomarkers.
  • Papel de ARID1A en la carcinogénesis endometrial dependiente de contexto. Análisis de los mecanismos moleculares y posibles implicaciones terapéuticas
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • IMPLEMENTATION OF PERSONALIZE MEDICINE IN CUTANEOUS MELANOMA BASED ON GENOMIC SUSCEPTIBILITY AND TUMOR SIGNATURES: IDENTIFICATION OF NEW TARGETS FOR MELANOMA TREATMENT
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
  • Estudio metabolómico del carcinoma de endometrio en relación a parametros morfológicos y moleculares